Cyberdyne saw no growth in patent filings in April and highest growth of 1.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Cyberdyne’s patent filings and grants. Buy the databook here.
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
Cyberdyne has been focused on protecting inventions in Japan(JP) with three publications in Q2 2024
The Japan(JP) Patent Office dominates the patent filings and grants with nearly 67% filings and 20% grants. The Japan(JP), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and United States(US) patent Office are among the top ten patent offices where Cyberdyne is filings its patents. Among the top granted patent authorities, Cyberdyne has 40% of its grants in European Patent Office(EPO), 40% in United States(US) and 20% in Japan(JP).
Safran could be the strongest competitor for Cyberdyne
Patents related to robotics and healthtech lead Cyberdyne's portfolio
Cyberdyne has the highest number of patents in robotics followed by, healthtech and connected patient. For robotics, nearly 100% of patents were filed and 20% of patents were granted in Q2 2024.
Active and passive safety related patents lead Cyberdyne portfolio followed by steering, and other remote patient monitoring
Cyberdyne has highest number of patents in active and passive safety followed by steering, other remote patient monitoring, industrial automation, and other communications equipment.
For comprehensive analysis of Cyberdyne's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

